Literature DB >> 23818203

Paeonol induces vasodilatation in rat mesenteric artery via inhibiting extracellular Ca²⁺ influx and intracellular Ca²⁺ release.

Jin-Yan Zhang1, Yong-Xiao Cao, Wei-Liang Weng, Yi-Kui Li, Le Zhao.   

Abstract

OBJECTIVE: To investigate the vasodilative effect of paeonol in rat mesenteric artery and the mechanisms responsible for it.
METHODS: Rats were anaesthetized and sacrificed. The superior mesenteric artery was removed, dissected free of adherent tissue and cut into 2.0 mm long cylindrical segments. Isometric tension of artery rings was recorded by a myograph system in vitro. Concentration-relaxation curves of paeonol (17.8 μ mol/L to 3.16 mmol/L) were recorded on artery rings precontracted by potassium chloride (KCl) and concentration-contraction curves of KCl, 5-hydroxytryptamine (5-HT), noradrenaline (NA) or calcium chloride (CaCl2) were recorded in the presence of paeonol (10(-4.5), 10(-3.8), 10(-3.5) mol/L) respectively. And also, concentration-relaxation curves of paeonol were recorded in the presence of different potassium channel inhibitors and propranolol on rings precontracted with KCl respectively. To investigate the role of intracellular Ca(2+) release from Ca(2+) store, the contraction induced by NA (100 μ mol/L) and CaCl2 (2 mmol/L) in Ca(2+) free medium was observed in the presence of paeonol respectively.
RESULTS: Paeonol relaxed artery rings precontracted by KCl in a concentration-dependent manner and the vasodilatation effect was not affected by endothelium denudation. Paeonol significant decreased the maximum contractions (Emax) induced by KCl, CaCl2, NA and 5-HT, as well as Emax induced by NA and CaCl2 in Ca(2+) -free medium, suggesting that paeonol dilated the artery via inhibiting the extracellular Ca(2+) influx mediated by voltage-dependent calcium channel, and receptor-mediated Ca(2+)-influx and release. Moreover, none of glibenclamide, tetraethylammonium, barium chlorded and propranolol affected the paeonol-induced vasodilatation, indicating that the vasodilatation was not contributed to ATP sensitive potassium channel, calcium-activated potassium channel, inwardly rectifying potassium channel, and β-adrenoceptor.
CONCLUSION: Paeonol induces non-endothelium dependent-vasodilatation in rat mesenteric artery via inhibiting voltage-dependent calcium channel-mediated extracellular Ca(2+) influx and receptor-mediated Ca(2+) influx and release.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818203     DOI: 10.1007/s11655-013-1505-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  14 in total

1.  Anemoside A3-induced relaxation in rat renal arteries: role of endothelium and Ca2+ channel inhibition.

Authors:  Dong-Mei Zhang; Shun-Ming Lin; Chi-Wai Lau; Anita Yiu; Jiao Wang; Yong Li; Chun-Lin Fan; Yu Huang; Wen-Cai Ye
Journal:  Planta Med       Date:  2010-05-26       Impact factor: 3.352

2.  The effects of paeonol on the electrophysiological properties of cardiac ventricular myocytes.

Authors:  Yu-ling Ma; Susan Bates; Alison M Gurney
Journal:  Eur J Pharmacol       Date:  2006-07-01       Impact factor: 4.432

3.  Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release.

Authors:  Yong-Xiao Cao; Wei Zhang; Jian-Yu He; Lang-Chong He; Cang-Bao Xu
Journal:  Vascul Pharmacol       Date:  2006-05-19       Impact factor: 5.773

4.  Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.

Authors:  F Sam; D B Sawyer; Z Xie; D L Chang; S Ngoy; D A Brenner; D A Siwik; K Singh; C S Apstein; W S Colucci
Journal:  Circ Res       Date:  2001-08-17       Impact factor: 17.367

5.  [Protective effect of paeonol on repeated cerebral ischemia in rats].

Authors:  G Zhang; Z Yu; H Zhao
Journal:  Zhong Yao Cai       Date:  1997-12

6.  [Anti-ischemia reperfusion damage and anti-lipid peroxidation effects of paeonol in rat heart].

Authors:  W G Zhang; Z S Zhang
Journal:  Yao Xue Xue Bao       Date:  1994

7.  Dimethylsulfoxide-soluble smoking particles and nicotine affect vascular contractibility.

Authors:  Jin-Yan Zhang; Lei Cao; Xiao-Hui Zheng; Cang-Bao Xu; Yong-Xiao Cao
Journal:  Arch Pharm Res       Date:  2009-11-08       Impact factor: 4.946

8.  Suppression of formalin-induced nociception by cilnidipine, a voltage-dependent calcium channel blocker.

Authors:  Hajime Koganei; Masataka Shoji; Seinosuke Iwata
Journal:  Biol Pharm Bull       Date:  2009-10       Impact factor: 2.233

9.  Neurally-derived nitric oxide regulates vascular tone in pulmonary and cutaneous arteries of the toad, Bufo marinus.

Authors:  Brett L Jennings; John A Donald
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-27       Impact factor: 3.619

10.  Protective effects of gabapentin on allodynia and alpha 2 delta 1-subunit of voltage-dependent calcium channel in spinal nerve-ligated rats.

Authors:  Tae Soo Hahm; Hyun Joo Ahn; Chang-Dae Bae; Han-Seop Kim; Seung Woon Lim; Hyun Sung Cho; Sangmin M Lee; Woo Seog Sim; Jie Ae Kim; Mi Sook Gwak; Soo Joo Choi
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more
  3 in total

1.  Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow.

Authors:  Lina Ma; Chia-Chen Chuang; Weiliang Weng; Le Zhao; Yongqiu Zheng; Jinyan Zhang; Li Zuo
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

2.  Chronic treatment with paeonol improves endothelial function in mice through inhibition of endoplasmic reticulum stress-mediated oxidative stress.

Authors:  Ker Woon Choy; Yeh Siang Lau; Dharmani Murugan; Mohd Rais Mustafa
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

3.  Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1.

Authors:  Lei Zhang; Zhiquan Chen; Wenyan Gong; Yezi Zou; Futian Xu; Lihao Chen; Heqing Huang
Journal:  Front Pharmacol       Date:  2018-05-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.